Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Randomized Controlled Trial
. 2007 May;191(4):1023-6.
doi: 10.1007/s00213-007-0740-0. Epub 2007 Feb 23.

Aripiprazole in treatment of borderline patients, part II: an 18-month follow-up

Marius K Nickel  1 , Thomas H Loew, Francisco Pedrosa Gil
Affiliations
Randomized Controlled Trial

Aripiprazole in treatment of borderline patients, part II: an 18-month follow-up

Marius K Nickel et al. Psychopharmacology (Berl). 2007 May.

Abstract

Rationale: Only one controlled trial is known that employed aripiprazole for patients with borderline personality disorder (BPD). This 8-week trial found significant changes on most scales of the symptom checklist (SCL-90-R), Hamilton depression rating scale (HDRS), Hamilton anxiety rating scale (HARS), and on all scales of the state-trait anger expression inventory (STAXI). OBJECTIVES, MATERIALS, AND METHODS: To assess the long-term effectiveness of aripiprazole with multifaceted borderline symptomatology, this 18-month follow-up observation with biannual testing was carried out with the same patients from the previous trial (treated with 15-mg aripiprazole daily, n = 26, 21 female and 5 male patients; previous placebo group, n = 26, 22 female and 4 male patients).

Results: According to the intent-to-treat principle, significant changes on all scales of the SCL-90-R, HDRS, HARS, and STAXI were observed in the aripiprazole-treated subjects after 18 months.

Conclusion: Aripiprazole appears to be an effective and relatively safe agent in the long-term treatment of patients with BPD.

PubMed Disclaimer

References

    1. Br J Soc Clin Psychol. 1967 Dec;6(4):278-96 - PubMed
    1. Clin Neuropharmacol. 1993 Oct;16(5):387-400 - PubMed
    1. Am J Psychiatry. 2004 Oct;161(10):1926-7 - PubMed
    1. J Pers Disord. 2003 Jun;17(3):233-42 - PubMed
    1. Br J Med Psychol. 1959;32(1):50-5 - PubMed

Publication types

LinkOut - more resources